TUCSON, Ariz. and MILAN, Italy--(BUSINESS WIRE)--Bracco Imaging S.p.A., through its affiliate Bracco International B.V. and ImaRx Therapeutics, Inc., today announced that they have entered into a Cross License Agreement with respect to certain patents and patent applications related to the use of microbubbles and ultrasound for targeted diagnostic and therapeutic applications.
